시장보고서
상품코드
1572002

세계의 자가 수혈 기기 시장

Autotransfusion Devices

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 192 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

자가 수혈 기기 시장은 2030년까지 24억 달러에 이를 것으로 예상됩니다.

2023년에 16억 달러로 추정된 자가 수혈 기기 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 5.5%로 성장하고 2030년에는 24억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 온펌프 수혈 장치는 복합 연간 성장률(CAGR) 5.8%로 성장을 지속하고, 분석 기간이 끝날 때까지 11억 달러에 이를 것으로 예측됩니다. 오프 펌프 수혈 장치 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.2%로 추정됩니다.

미국 시장은 4억 4,370만 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 5.2%로 성장할 것으로 예측됩니다.

미국의 자가 수혈 기기 시장은 2023년 4억 4,370만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 예측 기간 동안 복합 연간 성장률(CAGR) 5.2%로 성장을 지속하여 2030년에는 3억 7,120만 달러 규모에 이를 것으로 예측되고 있습니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 5.2%와 4.5%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 4.6%로 성장할 것으로 예측됩니다.

세계의 자가 수혈 기기 시장 - 주요 동향과 촉진요인 요약

현대의 의료 현장에서 자가 수혈 기기가 불가결해지고 있는 이유란?

자가 수혈 기기는 현대 의료 현장, 특히 출혈을 최소화하고 기증자 혈액에 대한 의존도를 줄이는 것이 중요한 수술에서 점점 더 중요 해지고 있습니다. 이러한 장치는 환자 자신의 혈액을 채취, 여과 및 재주입할 수 있게 하고, 기증자 수혈을 대체하는 보다 안전하고 효율적인 대안을 제공합니다. 수술, 특히 심혈관 수술 및 정형외과 수술 등 대량 출혈이 일반적인 수술 건수 증가는 자가 수혈 기기 시장의 주요 촉진요인입니다. 또한 감염, 면역 반응, 혈액 부족 등 수혈과 관련된 위험을 최소화할 필요성이 병원 및 수술센터에서 이러한 장비의 채택을 더욱 촉진하고 있습니다.

기술의 진보는 어떻게 자가 수혈 기기 시장을 형성하는가?

기술의 진보는 자가 수혈 기기의 효율성과 기능성을 크게 향상시켜 신뢰성과 사용 편의성을 높입니다. 자동화된 폐쇄 루프 시스템과 같은 기술 혁신은 채혈 및 처리 속도와 정확성을 향상시키면서 오염 위험을 최소화합니다. 최신의 자동 수혈 시스템은 보다 컴팩트하고 휴대가 가능하므로 다양한 수술 환경에서 보다 유연하고 사용하기 편리합니다. 또한, 고도의 여과 기술은 채취된 혈액의 품질을 개선하고, 재주입되는 혈액에 혈전이나 불순물이 없는 것을 보장하여 수술 중 환자의 안전성과 치료 성적을 향상시킵니다.

헬스케어 동향의 변화와 환자 요구는 시장에 어떤 영향을 미치는가?

환자의 안전성, 의료의 질, 비용 효율성을 중시하는 경향이 강해지고 있는 것이, 자가 수혈 기기의 채용에 크게 영향을 미치고 있습니다. 헬스케어 제공업체는 수혈 관련 합병증의 위험을 최소화하고 헬스케어 비용을보다 효과적으로 관리하기 위해 노력하고 있으며, 자기 수혈은 기증자 혈액 의존도를 줄임으로써 가능한 해결책을 제시합니다. 또한 심혈관 질환과 복잡한 수술이 필요한 외상 사례와 같은 만성 질환의 유병률이 증가하면 첨단 혈액 관리 솔루션의 필요성이 높아지고 있습니다. 환자는 또한 감염 및 면역학적 반응과 같은 기증자 혈액과 관련된 위험에 대한 더 많은 정보를 얻게 되었으며, 보다 안전한 대안으로서 자가혈수혈의 수용 확대로 이어지고 있습니다.

자가 수혈 기기 시장의 성장은 여러 요인에 의해 견인되고 있습니다.

자가 수혈 기기 시장의 성장은 출혈을 최소화하기 위해 효율적인 혈액 관리가 필요한 심혈관 수술, 정형외과, 외상 수술과 같은 복잡한 수술 증가와 같은 여러 요인에 의한 견인 되었습니다. 감염증이나 면역반응 등 수혈 관련 리스크의 경감에 주목이 모여 있는 것도 자동 수혈 시스템의 채용을 뒷받침하고 있습니다. 혈액 여과 및 채취 기술의 기술적 진보는 이러한 장치의 효능과 안전성을 향상시키고 그 사용을 더욱 촉진하고 있습니다. 다른 시장 성장 촉진요인은 자주 외과적 개입이 필요한 만성 질환의 유병률 증가와 기증자 혈액 대신 환자 자신의 혈액을 사용하는 혜택에 대한 의식 증가를 포함합니다.

조사 대상 기업 예(주목의 38사)

  • Advancis Surgical
  • Atrium Medical Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

BJH 24.10.24

Global Autotransfusion Devices Market to Reach US$2.4 Billion by 2030

The global market for Autotransfusion Devices estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. On Pump Transfusion Devices, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Off Pump transfusion Devices segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$443.7 Million While China is Forecast to Grow at 5.2% CAGR

The Autotransfusion Devices market in the U.S. is estimated at US$443.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$371.2 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Autotransfusion Devices Market - Key Trends & Drivers Summarized

Why Are Autotransfusion Devices Becoming Essential in Modern Medical Practices?

Autotransfusion devices are becoming increasingly important in modern medical practices, especially in surgeries where minimizing blood loss and reducing dependence on donor blood is crucial. These devices allow for the collection, filtration, and reinfusion of a patient’s own blood, providing a safer and more efficient alternative to donor blood transfusions. The rise in the number of surgical procedures, particularly cardiovascular and orthopedic surgeries, where significant blood loss is common, is a key driver for the autotransfusion devices market. Additionally, the need to minimize the risks associated with blood transfusions, such as infections, immune reactions, and blood shortages, is further propelling the adoption of these devices in hospitals and surgical centers.

How Are Technological Advancements Shaping the Autotransfusion Devices Market?

Technological advancements have significantly enhanced the efficiency and functionality of autotransfusion devices, making them more reliable and user-friendly. Innovations such as automated, closed-loop systems have minimized the risk of contamination while improving the speed and accuracy of blood collection and processing. Modern autotransfusion systems are also more compact and portable, allowing for greater flexibility and ease of use in diverse surgical settings. Additionally, advanced filtration technologies have improved the quality of the collected blood, ensuring that reinfused blood is free from clots and impurities, thereby enhancing patient safety and outcomes during surgeries.

How Are Shifting Healthcare Trends and Patient Needs Impacting the Market?

The growing emphasis on patient safety, quality of care, and cost efficiency is significantly influencing the adoption of autotransfusion devices. With healthcare providers striving to minimize the risk of transfusion-related complications and manage healthcare costs more effectively, autotransfusion presents a viable solution by reducing reliance on donor blood. Moreover, the increasing prevalence of chronic conditions, such as cardiovascular disease and trauma cases requiring complex surgeries, has driven the need for advanced blood management solutions. Patients are also becoming more informed about the risks associated with donor blood, such as infections and immunological reactions, leading to greater acceptance of autologous blood transfusion as a safer alternative.

The Growth in the Autotransfusion Devices Market Is Driven by Several Factors.

The growth in the autotransfusion devices market is driven by several factors, including the increasing number of complex surgical procedures, such as cardiovascular, orthopedic, and trauma surgeries, that require efficient blood management to minimize blood loss. The growing focus on reducing transfusion-related risks, such as infections and immune reactions, is also driving the adoption of autotransfusion systems. Technological advancements in blood filtration and collection techniques have improved the efficacy and safety of these devices, further promoting their usage. Additionally, the rising prevalence of chronic diseases that necessitate frequent surgical interventions, coupled with the growing awareness of the benefits of using a patient's own blood instead of donor blood, are key drivers of market growth.

Select Competitors (Total 38 Featured) -

  • Advancis Surgical
  • Atrium Medical Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Autotransfusion Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular and Orthopedic Surgeries Driving Autotransfusion Adoption
    • Rising Concerns Over Blood-Borne Infections Boosting Demand for Autologous Blood Transfusion
    • Technological Advancements in Autotransfusion Devices Improving Efficiency and Safety
    • Growing Focus on Minimizing Donor Blood Dependency in Surgery Settings
    • Expanding Adoption of Autotransfusion in Trauma and Emergency Care Situations
    • Government Initiatives Promoting Blood Management Solutions in Healthcare Facilities
    • Shift Towards Minimally Invasive Surgeries Driving the Use of Advanced Blood Recovery Devices
    • Increasing Awareness About Blood Conservation Techniques Among Healthcare Professionals
    • Rising Number of Cancer Surgeries Requiring Effective Blood Management Solutions
    • Growth in Geriatric Population Increasing Surgical Procedures and Autotransfusion Use
    • Enhanced Filtration Technologies Improving Blood Quality in Autotransfusion Devices
    • Cost-Effectiveness and Reduced Risks Promoting the Adoption of Autotransfusion Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Autotransfusion Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Autotransfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Autotransfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Autotransfusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for On Pump Transfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for On Pump Transfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for On Pump Transfusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Off Pump transfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Off Pump transfusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Off Pump transfusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cardiac Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Autotransfusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Autotransfusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Autotransfusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Autotransfusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Autotransfusion Devices by Type - On Pump Transfusion Devices and Off Pump transfusion Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Autotransfusion Devices by Type - Percentage Breakdown of Value Sales for On Pump Transfusion Devices and Off Pump transfusion Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Autotransfusion Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Autotransfusion Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Cardiac Research Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제